Skip to main content
Contact Us
Subscribe
E-Edition
84°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Legend Biotech Corp ADR
(NQ:
LEGN
)
57.38
+0.92 (+1.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Legend Biotech Corp ADR
< Previous
1
2
3
4
5
6
7
8
9
Next >
Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine
May 02, 2023
Johnson & Johnson's (NYSE: JNJ) pharma unit Janssen
Via
Benzinga
After Jumping 49% in 1 Month, Is It Too Late to Buy Legend Biotech?
May 01, 2023
Legend's cell therapy seems like it's a winner, but it might be priced in already.
Via
The Motley Fool
Potential Breakout Setups To Watch On Wednesday
April 26, 2023
The U.S. stock market has weakened throughout Tuesday’s trading session and the major indices were sitting near session lows heading into the closing bell.
Via
Benzinga
Why Legend Biotech Stock Is Having Its Best Month Yet
April 25, 2023
With the biotech market’s focus back on treatments for cancer and other life-threatening diseases, Legend has now tripled off its bottom to a record high.
Via
MarketBeat
Legend Bio Hits Profit-Taking Zone After Reportedly Confirming Key Study Results
April 21, 2023
Legend Bio is on a run on excitement for its multiple myeloma treatment.
Via
Investor's Business Daily
The Latest Analyst Ratings for Legend Biotech
April 18, 2023
Via
Benzinga
Where Legend Biotech Stands With Analysts
March 29, 2023
Via
Benzinga
The Latest Analyst Ratings for Legend Biotech
January 24, 2023
Via
Benzinga
Why Shares of Geron Are Up 30% This Week
April 20, 2023
The company's CEO was scheduled to speak at a virtual conference on Thursday.
Via
The Motley Fool
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
April 20, 2023
Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. There have been plenty of attention-grabbing headlines, and earnings season is...
Via
Benzinga
7 Biotech Stocks That Could Cure Your Portfolio Woes
April 19, 2023
If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
April 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 19, 2023
Via
Benzinga
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 19, 2023
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.
Via
Benzinga
Why Shares of Legend Biotech Jumped Wednesday
April 19, 2023
A leaked abstract on a phase 3 trial for the company's multiple myeloma drug Carvykti gave the stock a jolt.
Via
The Motley Fool
Legend Biotech Corp. (NASDAQ: LEGN) Leading the Way in Wednesday Trading Based on Percentage Gain
April 19, 2023
Via
Investor Brand Network
Legend Biotech Breaks Out After Leaked Documents Show Big CAR-T Benefit
April 19, 2023
The company could have the best-in-class CAR-T drug for multiple myeloma patients.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 19, 2023
Via
Benzinga
Western Alliance Bancorporation, Intuitive Surgical And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
April 19, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. Western Alliance Bancorporation (NYSE: WAL) shares jumped 15.4% to $37.50...
Via
Benzinga
Legend Biotech Announces Appointment of Chief Medical Officer
April 11, 2023
From
Legend Biotech
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
April 07, 2023
Via
Benzinga
Legend Biotech Establishes Strategic Advisory Board
April 03, 2023
From
Legend Biotech
Via
Business Wire
Legend Biotech Reports Full-Year 2022 Results and Recent Highlights
March 30, 2023
From
Legend Biotech
Via
Business Wire
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures
March 29, 2023
For those that can handle the heat, these biotech stocks to buy undergird some of the most powerful innovations in medicine.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
March 29, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2023
March 24, 2023
Via
Benzinga
Legend Biotech Announces Participation in Upcoming Investor Conferences
February 24, 2023
From
Legend Biotech
Via
Business Wire
Legend Biotech Regains Compliance with NASDAQ Listing Rule 5250(c)(2)
February 21, 2023
From
Legend Biotech
Via
Business Wire
Week In Review: HutchMed Announces $1.1 Billion Deal With Takeda For Colorectal Cancer Drug
January 28, 2023
Shanghai’s HutchMed out-licensed global rights for a colorectal cancer therapy to Japan’s Takeda in a deal worth up to $1.13 billion, including $400 million upfront. In addition to the $1.13 billion,...
Via
Talk Markets
Legend Biotech Announces Phase 3 CARTITUDE-4 Study of CARVYKTI® (ciltacabtagene autoleucel) Has Met Its Primary Endpoint in the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
January 27, 2023
From
Legend Biotech
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.